Interestingly, previous research has documented high CLDN11 expression in tumour cells from human lung squamous cell carcinoma 127, reinforcing the idea that the downregulation of CLDN11 identified in our analysis may predominantly arise from EndMT in endothelial cells. This evidence concerns the gene CLDN11 and neoplasm.